IRIS Accounts Production v23.3.0.418 13563421 Board of Directors Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure135634212022-03-31135634212023-03-31135634212022-04-012023-03-31135634212021-08-11135634212021-08-122022-03-31135634212022-03-3113563421ns16:EnglandWales2022-04-012023-03-3113563421ns15:PoundSterling2022-04-012023-03-3113563421ns11:Director12022-04-012023-03-3113563421ns11:Director22022-04-012023-03-3113563421ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3113563421ns11:SmallEntities2022-04-012023-03-3113563421ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3113563421ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3113563421ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3113563421ns11:FullAccounts2022-04-012023-03-3113563421ns11:CompanySecretary12022-04-012023-03-3113563421ns11:RegisteredOffice2022-04-012023-03-3113563421ns6:CurrentFinancialInstruments2023-03-3113563421ns6:CurrentFinancialInstruments2022-03-3113563421ns6:Non-currentFinancialInstruments2023-03-3113563421ns6:Non-currentFinancialInstruments2022-03-3113563421ns6:ShareCapital2023-03-3113563421ns6:ShareCapital2022-03-3113563421ns6:RetainedEarningsAccumulatedLosses2023-03-3113563421ns6:RetainedEarningsAccumulatedLosses2022-03-3113563421ns6:ShortLeaseholdAssetsns6:LandBuildings2022-04-012023-03-3113563421ns6:PlantMachinery2022-04-012023-03-3113563421ns6:FurnitureFittings2022-04-012023-03-3113563421ns6:ComputerEquipment2022-04-012023-03-3113563421ns6:ShortLeaseholdAssetsns6:LandBuildings2022-03-3113563421ns6:PlantMachinery2022-03-3113563421ns6:FurnitureFittings2022-03-3113563421ns6:ComputerEquipment2022-03-3113563421ns6:ShortLeaseholdAssetsns6:LandBuildings2023-03-3113563421ns6:PlantMachinery2023-03-3113563421ns6:FurnitureFittings2023-03-3113563421ns6:ComputerEquipment2023-03-3113563421ns6:ShortLeaseholdAssetsns6:LandBuildings2022-03-3113563421ns6:PlantMachinery2022-03-3113563421ns6:FurnitureFittings2022-03-3113563421ns6:ComputerEquipment2022-03-3113563421ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3113563421ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3113563421ns6:AcceleratedTaxDepreciationDeferredTax2023-03-3113563421ns6:DeferredTaxation2022-03-3113563421ns6:DeferredTaxation2022-04-012023-03-3113563421ns6:DeferredTaxation2023-03-31
REGISTERED NUMBER: 13563421 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

Dati Medical Limited

Dati Medical Limited (Registered number: 13563421)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Dati Medical Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: D Brislen (Snr)
T N Guimaraes





SECRETARY:





REGISTERED OFFICE: 1 Pacific Road
Birkenhead
CH41 1LJ





REGISTERED NUMBER: 13563421 (England and Wales)





ACCOUNTANTS: Triton Accountancy Services Ltd
Suite 7 Lesscent House
405 Wigan Rd
Ashton in Makerfield
Wigan
WN4 0AR

Dati Medical Limited (Registered number: 13563421)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 391,047 55,157

CURRENT ASSETS
Debtors 5 101,731 13,643
Cash at bank 5,030 13,865
106,761 27,508
CREDITORS
Amounts falling due within one year 6 1,051,558 76,370
NET CURRENT LIABILITIES (944,797 ) (48,862 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(553,750

)

6,295

CREDITORS
Amounts falling due after more than
one year

7

(913,097

)

(253,678

)

PROVISIONS FOR LIABILITIES 8 (38,124 ) -
NET LIABILITIES (1,504,971 ) (247,383 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (1,505,071 ) (247,483 )
(1,504,971 ) (247,383 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dati Medical Limited (Registered number: 13563421)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2023 and were signed on its behalf by:




D Brislen (Snr) - Director



T N Guimaraes - Director


Dati Medical Limited (Registered number: 13563421)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Dati Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - 20% on cost
Plant and machinery - 15% on cost
Fixtures and fittings - 15% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Dati Medical Limited (Registered number: 13563421)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2022 - 5 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and Computer
leasehold machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2022 - 4,777 39,342 17,088 61,207
Additions 300,000 6,759 107,850 2,556 417,165
At 31 March 2023 300,000 11,536 147,192 19,644 478,372
DEPRECIATION
At 1 April 2022 - 300 3,000 2,750 6,050
Charge for year 60,000 1,224 13,990 6,061 81,275
At 31 March 2023 60,000 1,524 16,990 8,811 87,325
NET BOOK VALUE
At 31 March 2023 240,000 10,012 130,202 10,833 391,047
At 31 March 2022 - 4,477 36,342 14,338 55,157

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 8,448 -
VAT 13,852 12,493
Deferred tax asset - 1,150
Prepayments 79,431 -
101,731 13,643

Dati Medical Limited (Registered number: 13563421)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade creditors 999,622 73,997
Social security and other taxes 36,291 1,732
Other creditors 2,595 641
Accrued expenses 13,050 -
1,051,558 76,370

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.3.23 31.3.22
£    £   
Amounts owed to associates 913,097 253,678

8. PROVISIONS FOR LIABILITIES
31.3.23
£   
Deferred tax
Accelerated capital allowances 38,124

Deferred
tax
£   
Balance at 1 April 2022 (1,150 )
Provided during year 39,274
Balance at 31 March 2023 38,124